Abdera Therapeutics, Inc.
🇨🇦Canada
Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Study of 225Ac-ABD147 to Establish Optimal Dose in Patients With SCLC and LCNEC of the Lung That Previously Received Platinum-based Chemotherapy
Phase 1
Recruiting
- Conditions
- Small-Cell Lung Cancer (SCLC)Large Cell Neuroendocrine Carcinoma of the Lung
- Interventions
- First Posted Date
- 2024-12-16
- Last Posted Date
- 2025-06-04
- Lead Sponsor
- Abdera Therapeutics Inc.
- Target Recruit Count
- 65
- Registration Number
- NCT06736418
- Locations
- 🇺🇸
MD Anderson, Houston, Texas, United States
🇺🇸Hoag Memorial Hospital Presbyterian, Newport Beach, California, United States
🇺🇸United Theranostics, Glen Burnie, Maryland, United States
News
No news found